Excerpt of an article published in The Huffington Post with first-hand accounts of how sequestration is impacting scientific research.
When The Huffington Post published an in-depth look at how budget cuts were affecting scientific research, we encouraged readers to offer reactions and share personal experiences.
Excerpt of an op-ed by columnist George F. Will, published in The Washington Post.
’The capacity to blunder slightly is the real marvel of DNA. Without this special attribute, we would still be anaerobic bacteria and there would be no music.’
Excerpt of an article published by The Salt Lake Tribune on sequestration’s impact to research institutions in Utah.
Op-ed by The Honorable John Edward Porter, Research!America Chair and former U.S. Representative (1980 ’ 2001) published in CNN.
Dear Research Advocate:
By Tyler Wiechman
Wiechman currently works in the cardiovascular specialty of a privately owned pharmaceutical company working with specialists and hospitals in the Central Pennsylvania Region. He withdrew from a PhD in biomedical sciences from the Penn State University Hershey College of Medicine and received his BS in Psychology from the University of Delaware in 2011. He has worked for three different labs focusing on Neurological/Psychological health and behavior.
The Foundation for the National Institutes of Health (FNIH) is accepting nominations for the 2014 Lurie Prize in the Biomedical Sciences, an annual award recognizing outstanding achievement by a young scientist in biomedical research.
The Prize? $100,000, made possible by a generous gift from Ann Lurie, FNIH Board Member, distinguished philanthropist and president of the Ann and Robert H. Lurie Foundation.
John Eng, MD, was recently named as the latest winner of the Golden Goose Awards. Eng is the second winner announced in 2013, and others will be named in the coming weeks. The Golden Goose Award was created last year to celebrate researchers whose seemingly odd or obscure federally funded research turned out to have a significant, positive impact on society.
Dear Research Advocate:
The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’t accounted for that way on the federal books. The arguments we’ve been making are now further bolstered by the BEA’s decision. Spread the word!